Terns, Inc.
Clinical trials sponsored by Terns, Inc., explained in plain language.
Now part of
Terns Pharmaceuticals, Inc.
TERN
NASDAQ
Biopharmaceutical company developing treatments for liver diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.